|4/AMar 12, 5:11 PM ET

AUXILIUM PHARMACEUTICALS INC 4/A

4/A · AUXILIUM PHARMACEUTICALS INC · Filed Mar 12, 2014

Insider Transaction Report

Form 4/AAmended
Period: 2013-02-07
JOBES ELIZABETH VARKI
Chief Compliance Officer
Transactions
  • Award

    Common Stock

    2013-02-07+6,0009,000 total
  • Award

    Common Stock

    2014-02-18+5,50018,124 total
Footnotes (2)
  • [F1]Footnote No. 1 in the Form 4 originally filed on February 11, 2013 contained an error regarding the vesting schedule of the restricted stock units awarded to reporting person. Footnote No. 1 is hereby corrected as follows: The restricted stock units vest in 3 installments as follows: 33.33% on March 7, 2014 and 33.33% each on February 7, 2015 and on February 7, 2016.
  • [F2]Footnote No. 3 in the Form 4 originally filed on February 20, 2014 contained an error regarding the vesting schedule of the restricted stock units awarded to reporting person. Footnote No. 3 is hereby corrected as follows: The restricted stock units vest in 3 installments as follows: 33.33% on March 18, 2015 and 33.33% each on February 18, 2016 and on February 18, 2017.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION